Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation.
Ward A, Quon P, Abouzaid S, Haber N, Ahmed S, Kim E. Ward A, et al. Among authors: quon p. P T. 2013 Feb;38(2):109-15. P T. 2013. PMID: 23599678 Free PMC article.
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.
Quon P, Le HH, Raymond V, Mtibaa M, Moshyk A. Quon P, et al. J Med Econ. 2016 Jun;19(6):557-67. doi: 10.3111/13696998.2016.1141780. Epub 2016 Feb 3. J Med Econ. 2016. PMID: 26761644
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada.
Quon PL, Xiao Y, Sorensen S, Monfared AAT. Quon PL, et al. Pharmacoecon Open. 2019 Sep;3(3):321-331. doi: 10.1007/s41669-018-0112-1. Pharmacoecon Open. 2019. PMID: 30617952 Free PMC article.
Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism.
Lanitis T, Hamilton M, Rublee DA, Leipold R, Quon P, Browne C, Cohen AT. Lanitis T, et al. Among authors: quon p. Value Health. 2014 Nov;17(7):A488. doi: 10.1016/j.jval.2014.08.1434. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201443 Free article. No abstract available.
Lifetime Clinical Events Avoided And Resource Utilization With Apixaban Compared To Low-Molecular-Weight Heparin Followed By A Vitamin K Antagonist For The Treatment And Prevention Of Venous Thromboembolism.
Hamilton M, Phatak H, Lanitis T, Mardekian J, Rublee DA, Leipold R, Quon P, Browne C, Cohen AT. Hamilton M, et al. Among authors: quon p. Value Health. 2014 Nov;17(7):A475. doi: 10.1016/j.jval.2014.08.1358. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201370 Free article. No abstract available.
[No authors listed] [No authors listed] PMID: 26532117
[No authors listed] [No authors listed] PMID: 26532232
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.
Lanitis T, Leipold R, Hamilton M, Rublee D, Quon P, Browne C, Cohen AT. Lanitis T, et al. Among authors: quon p. BMC Health Serv Res. 2017 Jan 23;17(1):74. doi: 10.1186/s12913-017-1995-8. BMC Health Serv Res. 2017. PMID: 28114939 Free PMC article.
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.
Lanitis T, Leipold R, Hamilton M, Rublee D, Quon P, Browne C, Cohen AT. Lanitis T, et al. Among authors: quon p. Clin Ther. 2016 Mar;38(3):478-93.e1-16. doi: 10.1016/j.clinthera.2016.01.020. Epub 2016 Feb 26. Clin Ther. 2016. PMID: 26922297
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC, Tafesse E, Quon P, Lazarus A. Woodward TC, et al. Among authors: quon p. Pharmacoeconomics. 2010;28(9):751-64. doi: 10.2165/11538350-000000000-00000. Pharmacoeconomics. 2010. PMID: 20623994
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback